| Patents for C07C 65 - Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (5,447) |
|---|
| 12/28/2004 | US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 12/23/2004 | US20040258852 Novel acid anhydride and polyimide using the same |
| 12/22/2004 | EP1489079A1 Anhydrides and their polyimide derivatives |
| 12/22/2004 | CN1556091A Method of eliminating metal ion impurity in industrial galli acid |
| 12/15/2004 | EP0934244B1 Method for selective preparation of a 2-hydroxybenzoic acid and a 4-hydroxybenzaldehyde and derivatives |
| 12/09/2004 | WO2004099280A3 Process of making press molded materials using heat activated tertiary amine urethane catalysts |
| 12/09/2004 | US20040248026 excellent triboelectric charge property; for electrophotographic toners, nontoxic |
| 12/09/2004 | CA2527691A1 Condensed ring compound |
| 12/08/2004 | EP0920312B1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 12/08/2004 | CN1553800A Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 12/02/2004 | WO2004103074A1 Copper salts of organic acids and use thereof as fungicides |
| 12/02/2004 | US20040242828 Ozonolysis; reduction to phenolic compounds and aldehydes ; using transition metal catalyst and reducing sugar; adhesive for particle board |
| 12/02/2004 | US20040237837 Benzophenone derivative linked to hydrophylic moiety; concurrently imparts wettability and long term storage stability |
| 11/30/2004 | US6825233 Substituted bonzoic acid derivatives, useful for preventing and/or treating tumors, arthritis, and non-malignant skin disorders |
| 11/25/2004 | WO2004073611A3 Compounds for the treatment of metabolic disorders |
| 11/25/2004 | WO2004067489A3 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 11/25/2004 | WO2003101945A8 Ligands that are inhibitors of the rar receptors |
| 11/23/2004 | CA2310745C Oxygen scavenging hydrotalcite and compositions containing same |
| 11/23/2004 | CA2104635C Composition for the treatment of acne containing a salicylic acid derivative, and salicylic acid derivatives |
| 11/18/2004 | WO2004099280A2 Process of making press molded materials using heat activated tertiary amine urethane catalysts |
| 11/18/2004 | WO2004099279A2 Heat activated tertiary amine urethane catalysts |
| 11/18/2004 | US20040230066 Production method of citalopram, intermediate therefor and production method of the intermediate |
| 11/18/2004 | US20040229326 produced from host microoganism cultures and solvent extraction |
| 11/18/2004 | CA2524267A1 Heat activated tertiary amine urethane catalysts |
| 11/18/2004 | CA2524260A1 Process of making press molded materials using heat activated tertiary amine urethane catalysts |
| 11/11/2004 | US20040224844 Use of hydroxyaromatic compounds as safeners |
| 11/10/2004 | EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE |
| 11/04/2004 | WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use |
| 11/02/2004 | CA2129040C Styryl derivatives and processes for their preparation |
| 10/28/2004 | WO2004092392A2 A method for producing para-hydroxystyrene and other multifunctional aromatic compounds using two-phase extractive fermentation |
| 10/28/2004 | WO2004092344A2 A method for preparing para-hydroxystyrene by biocatalytic decarboxylation of para-hydroxycinnamic acid in a biphasic reaction medium |
| 10/28/2004 | WO2004092249A1 Perdeuterated poliimides, method for the production and use thereof in the form of transparent materials in the range of 2500-3500 cm-1 |
| 10/28/2004 | WO2003018515A3 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 10/28/2004 | US20040214887 for example, 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid, 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol, 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; treatment of Alzheimer's Disease, metabolic syndrome disorder, cancer, cardiovascular disease, diabetic nephropathy |
| 10/28/2004 | CA2497079A1 Perdeuterated poliimides, method for the production and use thereof in the form of transparent materials in the range of 2500-3500 cm-1 |
| 10/21/2004 | WO2004089885A1 Novel compounds |
| 10/21/2004 | US20040209847 treating and preventing a variety of diseases and conditions such as aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic retinopathy, dyslipidemia, dyslipoproteinemia, hypertension, impotence, insulin resistance, peroxisome proliferator activated receptor associated disorders |
| 10/20/2004 | EP1468985A1 A process for the preparation of gabapentin free from inorganic acids anions |
| 10/20/2004 | CN1537846A Intermediates for making HIV-protease inhibitors and method for making HIV-protease inhibitors |
| 10/12/2004 | US6802874 Additives for lubricants and fuels |
| 10/12/2004 | CA2170394C Process for conditioning substances |
| 10/07/2004 | WO2004084631A1 Use of aromatic hydroxy compounds as safeners |
| 10/07/2004 | US20040199006 oxidation of aromatic hydrocarbons and/or aromatic aldehyde intermediates, in the presence of oxidation catalysts, to form carbocyclic acids |
| 10/07/2004 | CA2520228A1 Use of aromatic compounds as safeners |
| 10/06/2004 | CN1169775C Poly-basic aromatic carboxylic acid for flotation and its preparing method |
| 10/06/2004 | CN1169772C Extraction process of effective rhubarb component, fast released Sanhuang prepn and its prepn process |
| 09/30/2004 | WO2003093823A8 Chemically inert molecular alkane or oxaalkane-tags and their identification by reaction with fluoroalkanoyl acids |
| 09/30/2004 | US20040192740 for treating or preventing conditions associated with altered mitochondrial function with such compounds eg Alzheimer's Disease; diabetes mellitus; obesity; Parkinson's Disease; Huntington's disease; dystonia; Leber's hereditary optic neuropathy |
| 09/29/2004 | EP1462436A1 Halogen-containing aromatic compound |
| 09/23/2004 | WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use |
| 09/23/2004 | US20040186027 Linear compounds containing phenolic and salicylic units |
| 09/23/2004 | DE19544528B4 Ballistik-Modifizierungsmittel für Propergole, modifizierte Propergole und neue Bismutresorcylate Ballistic modifiers for propellants, modified propellants and new Bismutresorcylate |
| 09/16/2004 | WO2004069782A3 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 09/16/2004 | DE3717389B4 Neue naphthylaromatische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung in der Human- und Veterinärmedizin und in der Kosmetik New naphthylaromatische compounds, processes for their preparation and their use in human and veterinary medicine and cosmetics |
| 09/15/2004 | EP1456165A1 Induction of apoptosis in cancer cells |
| 09/15/2004 | CN1166675C Extractant, extraction process and analysis method of high-activity ginkgo leaf extractive |
| 09/14/2004 | US6790991 Fomesafen produced by nitrating 3-(2-chloro-a,a,a-trifluoro-4-tolyloxy)-benzoic acid to form acifluorfen, converting to its acid chloride, and then reaction with methanesulfonamide |
| 09/09/2004 | US20040176595 Glucocorticoid receptor modulators |
| 09/08/2004 | EP1095929B1 Crystal of 2-hydroxynaphthalene-3-carboxylic acid and process for the preparation thereof |
| 09/08/2004 | EP1094712A4 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 09/07/2004 | US6787562 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 09/07/2004 | CA2100031C Smoking compositions containing an alpha-alkylcinnamaldehyde-release additive |
| 09/02/2004 | WO2004073611A2 Compounds for the treatment of metabolic disorders |
| 09/02/2004 | US20040171871 Process for producing aromatic carboxylic acids |
| 09/01/2004 | EP1452517A1 Process for producing aromatic carboxylic acids |
| 08/26/2004 | WO2004058679A3 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 08/26/2004 | US20040167350 Bichlorinated compounds formed under with carboxy groupand elimation of water |
| 08/25/2004 | CN1523003A Novel 2-(alpha-hydroxyl amyl) and its preparing method and use |
| 08/25/2004 | CN1163548C Toning agent |
| 08/19/2004 | WO2004069782A2 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 08/18/2004 | EP1446376A1 Compositions based on cupric salts, cupric salts and their use for controlling phytopathogens |
| 08/17/2004 | US6777418 For treating or preventing emphysema, cancer and dermatological disorders |
| 08/12/2004 | WO2004067489A2 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 08/12/2004 | US20040158068 Method for oxidising an aromatic aldehyde into the corresponding carboxylic acid |
| 08/11/2004 | EP1445249A1 Novel bensophenone derivatives or salts thereof |
| 08/11/2004 | EP1443919A1 Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein |
| 08/11/2004 | CN1520391A Method for oxidising aromatic aldehyde into corresponding carboxylic acid |
| 08/05/2004 | US20040152913 Cleavable surfactants and methods of use thereof |
| 08/04/2004 | EP1441845A1 Method for the production of particles |
| 07/29/2004 | WO2004063148A1 Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia |
| 07/29/2004 | WO2004037213A3 Nuclear hormone receptor compounds, products and methods employing same |
| 07/28/2004 | CN1159283C Process for preparing 3,5-tert-butyl salicylic acid |
| 07/22/2004 | WO2003093823A3 Chemically inert molecular alkane or oxaalkane-tags and their identification by reaction with fluoroalkanoyl acids |
| 07/20/2004 | US6765113 Production of aromatic carboxylic acids |
| 07/20/2004 | CA2085555C Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them |
| 07/15/2004 | WO2004058747A1 Fc receptor modulating compounds and compositions |
| 07/15/2004 | WO2004058679A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 07/15/2004 | WO2004039753A3 Phenyl compounds |
| 07/15/2004 | US20040138497 Production method of citalopram, intermediate therefor and production method of the intermediate |
| 07/15/2004 | CA2511356A1 Fc receptor modulating compounds and compositions |
| 07/15/2004 | CA2511178A1 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 07/14/2004 | EP1437339A1 Substituted benzoic acid derivatives exhibiting nf-kappa b inhibiting activity |
| 07/14/2004 | EP1202996B9 Titanium derived compounds, preparation and use thereof |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/13/2004 | US6761879 Titanium derived compounds, preparation and use thereof |
| 07/08/2004 | WO2004046096A3 Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 07/08/2004 | US20040131648 Nuclear hormone receptor compounds, products and methods employing same |
| 07/06/2004 | US6759552 Insecticides, pesticides |
| 07/01/2004 | WO2004054956A1 Method for producing carboxylic acid |
| 07/01/2004 | US20040127495 Preferential suppressors of immunoglobulins, used as immunosuppressants and antiallergens |